Amarin Announces Notification of Patent Allowance for U.S. Application 13/610,217 Related to Vascepa® and FDA Approved MARINE Indication by longitudeadmin | Jan 11, 2013 | Portfolio News
Velomedix Receives Health Canada Approval for VELOCITY Pilot Study and Bolsters Leadership Team by longitudeadmin | Jan 9, 2013 | Portfolio News
Esperion announces positive topline results from a Phase 2 clinical trial of ETC-1002 in patients with type 2 diabetes by longitudeadmin | Jan 7, 2013 | Portfolio News
Alphatec Spine Receives U.S. FDA 510(K) Market Clearance for Two New Products and Receives Japanese Shonin Approval to Begin Marketing Its Novel(R) Peek Lumbar Spinal Spacers by longitudeadmin | Jan 1, 2013 | Portfolio News
Longitude Capital pumps $385M into new life sciences fund by longitudeadmin | Oct 11, 2012 | Longitude Capital News
